Zimmer Biomet Holdings (ZBH) Net Income Growth (1y) (2010 - 2026)
Zimmer Biomet Holdings (ZBH) Net Income Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.69% |
| 10 | Zimmer Biomet Holdings | 17.99 Bn | 17.57 Bn | 1.51 Bn | 30.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.58% |
| Dec 31, 2025 | -50.62% |
| Sep 30, 2025 | -7.22% |
| Jun 30, 2025 | -36.90% |
| Mar 31, 2025 | 5.61% |
| Dec 31, 2024 | -229.78% |
| Sep 30, 2024 | 53.07% |
| Jun 30, 2024 | 15.82% |
| Mar 31, 2024 | -25.74% |
| Mar 31, 2023 | 495.75% |
| Mar 31, 2022 | -1,351.06% |
| Dec 31, 2021 | -107.28% |
| Sep 30, 2021 | -106.75% |
| Jun 30, 2021 | 98.90% |
| Mar 31, 2021 | 100.92% |
| Dec 31, 2020 | 17.89% |
| Sep 30, 2020 | -45.12% |
| Jun 30, 2020 | -257.85% |
| Mar 31, 2020 | -306.78% |
| Dec 31, 2019 | 138.29% |